Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT06933420

Clinical Protocol CERN Feasibility Study

Led by Cern Corporation · Updated on 2025-04-18

9

Participants Needed

3

Research Sites

25 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if the intravaginal Cern device works to treat bacterial vaginosis and fungal vaginitis in premenopausal women. It will also learn about the safety of the device. The main questions it aims to answer are: Does the device accomplish symptom resolution and negative diagnostic tests post-treatment? What medical problems do participants have when using the intravaginal device? Participants will use the investigational intravaginal device for 5 consecutive days, participate in teleconferences and weekly follow-ups, attend in-clinic visits, and maintain a study diary.

CONDITIONS

Official Title

Clinical Protocol CERN Feasibility Study

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirm symptomatic and laboratory-confirmed bacterial vaginosis or fungal vaginitis
Not Eligible

You will not qualify if you...

  • Postmenopausal status
  • Current use of intravaginal devices
  • Concurrent medical therapy for fungal vaginitis or bacterial vaginosis
  • Recent medical therapy for vaginitis in past 7 days
  • Immunosuppressive medication within 3 months before screening
  • Radiation therapy within 3 months before screening
  • Known allergy to curcumin, acrylic, or silicone
  • Major organ disease or clinically significant infection or conditions affecting vaginitis assessment
  • Pregnancy or plans for pregnancy
  • History of intolerance to intravaginal devices
  • Symptomatic pelvic organ prolapse stage 2 or greater

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Akerman Med

Irvine, California, United States, 92618

Actively Recruiting

2

Akerman Med

Orange, California, United States, 92868

Actively Recruiting

3

Akerman Med

Santa Ana, California, United States, 92707

Actively Recruiting

Loading map...

Research Team

G

Gregg Klang

CONTACT

M

Melanie Santos

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Clinical Protocol CERN Feasibility Study | DecenTrialz